Stay updated on Telitacicept in Active Lupus Clinical Trial
Sign up to get notified when there's something new on the Telitacicept in Active Lupus Clinical Trial page.
Latest updates to the Telitacicept in Active Lupus Clinical Trial page
- Check2 days agoChange DetectedNew revision v3.3.4 appears in the history, replacing v3.3.3; this is a minor update to the page history and does not affect core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check9 days agoChange DetectedTerminated recruitment status was added, Vor Biopharma is listed as sponsor/collaborators, and 2026-01-09 appears in the history; Active, not recruiting and RemeGen Co., Ltd. were removed on 2024-11-19. The update involves changes to Study Status, Recruitment Status, Study Design, and Sponsor/Collaborators.SummaryDifference1%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.3 was added to the page history, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check52 days agoChange DetectedA new revision entry v3.3.2 was added, replacing the previous v3.3.1 in the page history. This appears to be a minor page update.SummaryDifference0.1%
- Check59 days agoChange DetectedRecord History now includes a new revision v3.3.1 and removes revision v3.2.0.SummaryDifference0.1%
- Check66 days agoChange DetectedRemoved the government funding notice about operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%
Stay in the know with updates to Telitacicept in Active Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Telitacicept in Active Lupus Clinical Trial page.